Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vesalius Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Vesalius Therapeutics

Vesalius Therapeutics

Series A

Vesalius Therapeutics: Innovating drug development to combat major human illnesses.

HQ
Cambridge, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Vesalius Therapeutics, founded by Flagship Pioneering, is dedicated to revolutionizing the treatment of diseases responsible for 90% of human illness. The company’s core mission is to fundamentally reconceptualize drug development for common diseases, aiming to improve patient outcomes through innovative therapeutic approaches. Vesalius Therapeutics focuses on creating groundbreaking treatments that address significant unmet medical needs, leveraging cutting-edge research and development methodologies.

Notable affiliates include Flagship Pioneering, a renowned venture capital firm known for nurturing transformative biotech companies. Vesalius Therapeutics has made significant strides in its field, marked by pioneering research and promising clinical advancements. The company's impact lies in its potential to redefine disease treatment paradigms, offering hope for more effective therapies for widespread health conditions.

Vesalius Therapeutics - Similar Companies

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Valo Health logo

Valo Health

valohealth.com

Ventus Therapeutics logo

Ventus Therapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Vasa Therapeutics logo

Vasa Therapeutics

Valerion Therapeutics logo

Valerion Therapeutics

Curie.Bio logo

Curie.Bio

curie.bio

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Chase Therapeutics logo

Chase Therapeutics

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Variant Bio logo

Variant Bio

variantbio.com

Vesalius Therapeutics - Quick Facts

Who are Vesalius Therapeutics' competitors?

Companies similar to Vesalius Therapeutics include ProFound Therapeutics, Ampersand Biomedicines, Valo Health and Ventus Therapeutics.

When was Vesalius Therapeutics founded?

Vesalius Therapeutics was founded in 2019.

Where is Vesalius Therapeutics' headquarters located?

Vesalius Therapeutics' headquarters is located in Cambridge, MA, US.

When was Vesalius Therapeutics' last funding round?

Vesalius Therapeutics' most recent funding round was for $75M (USD) in March 2022.

How much has Vesalius Therapeutics raised to-date?

As of Mar 2, 2022, Vesalius Therapeutics has raised a total of $75M (USD).

How many employees does Vesalius Therapeutics have?

Vesalius Therapeutics has 35 employees as of Feb 4, 2024.

Vesalius Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified